Posts tagged teva

Teva enhances CNS portfolio with Auspex acquisition

Staff, March 31, 2015

Israel’s Teva Pharmaceutical Industries Ltd has agreed to acquire U.S. biopharmaceutical firm Auspex Pharmaceuticals Inc, boosting its range of treatments for the central nervous system (CNS).

Pharmaceutical

Israel’s Teva to buy NuPathe for $144 million

Staff, January 27, 2014

Pennsylvania-based NuPathe specializes in therapeutics for diseases of the central nervous system (CNS), including neurological and psychiatric disorders.